TRK
Showing 76 - 96 of 96
Hepatitis C Viral Infection, Chronic Hepatitis C, Hepatitis C (HCV) Trial in New Zealand, United States (Faldaprevir, TD-6450,
Completed
- Hepatitis C Viral Infection
- +3 more
- Faldaprevir
- +2 more
-
Coronado, California
- +5 more
Oct 13, 2017
Tumor Pathway Activations Inhibited by Dovitinib Trial in United States (Dovitinib (TKI258))
Completed
- Tumor Pathway Activations Inhibited by Dovitinib
- Dovitinib (TKI258)
-
Birmingham, Alabama
- +48 more
Jan 30, 2017
Dynamic Thoracic Impedance asMarker for Heart Failure
Completed
- Heart Failure; With Decompensation
- Medtronic ICDs, CRT-Ds, and CRT-Ps
-
Kansas City, KansasUniversity of Kansas Medical Center
Apr 13, 2016
Arterial Hypertension Trial in Warsaw (lisinopril, Telmisartan, Nebivolol)
Completed
- Arterial Hypertension
- lisinopril
- +4 more
-
Warsaw, Mazovia, PolandMilitary Institute of Medicine
Mar 11, 2018
Hepatitis C Viral Infection, Chronic Hepatitis C, Hepatitis C (HCV) Trial in Coronado (Faldaprevir, TD-6450, Ribavirin)
Completed
- Hepatitis C Viral Infection
- +3 more
- Faldaprevir
- +2 more
-
Coronado, CaliforniaSouthern California Research Center
Jan 27, 2017
Chronic Renal Failure, Glomerular Disease, Nephrosclerosis Trial in Worldwide (TRK-100STP high dose, TRK-100STP low dose,
Completed
- Chronic Renal Failure
- +2 more
- TRK-100STP high dose
- +2 more
-
Beijing, China
- +6 more
Feb 3, 2015
Renal Impairment Trial in Japan (beraprost sodium(BPS))
Completed
- Renal Impairment
- beraprost sodium(BPS)
-
Japan, JapanJapan
Mar 3, 2014
Epigenetic Regulation of BDNF in Schizophrenia
Completed
- BDNF, DNA Methylation, Suicide, Drug Responses.
-
Kaohsiung, TaiwanDepartment of Psychiatry, Chang Gung Memorial Hospital
Sep 11, 2013
Neuroblastoma Trial in Worldwide (biological, drug, procedure, radiation)
Unknown status
- Neuroblastoma
- filgrastim
- +12 more
-
Vienna, Austria
- +31 more
Jun 23, 2014
Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis Trial in Seoul (nalfurafine HCl (TRK-820), Placebo)
Completed
- Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis
- nalfurafine hydrochloride (TRK-820)
- Placebo
-
Seoul, Korea, Republic ofSKchemicals Investigational Site
Jan 19, 2012
Osteoarthritis, Arthroplasty, Replacement, Knee Trial in Worcester (Patient support sessions, Treatment as usual)
Completed
- Osteoarthritis
- Arthroplasty, Replacement, Knee
- Patient support sessions
- Treatment as usual
-
Worcester, MassachusettsUniversity of Massachusetts Memorial Health Center; Arthritis an
Feb 24, 2013
Healthy Adult Male, Pharmacokinetics of TRK-100-STP Trial in Kyushu (TRK-100STP)
Completed
- Healthy Adult Male
- Pharmacokinetics of TRK-100-STP
-
Kyushu, Japan(unnamed)
Oct 2, 2011
Onabotulinumtoxina Intradetrusorial Injections and NGF
Completed
- Overactive Detrusor
- Detrusor Hyperreflexia of Bladder
-
Perugia, ItalyUniversity of Perugia, Dept. of Urology and Andrology
Jun 25, 2012
Chronic Renal Failure Trial in Seoul (nalfurafine HCl)
Completed
- Chronic Renal Failure
- nalfurafine hydrochloride
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 24, 2010
Pruritus With Chronic Liver Disease Trial in Urayasu (Nalfurafine Hydrochloride (TRK-820), Placebo)
Completed
- Pruritus With Chronic Liver Disease
- Nalfurafine Hydrochloride (TRK-820)
- Placebo
-
Urayasu, Chiba, JapanToray Industries, Inc
Jan 28, 2010
Healthy Trial in Tokyo (TRK-100STP (BERASUS LA), AST-120 (Kremezin®))
Completed
- Healthy
- TRK-100STP (BERASUS LA)
- AST-120 (Kremezin®)
-
Tokyo, Japan(unnamed)
Oct 9, 2008
Nephroblastoma, Neuroblastoma Trial run by the NCI (IFN-alpha with retinoic acid)
Completed
- Nephroblastoma
- Neuroblastoma
- IFN-alpha with retinoic acid
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Molecular Mechanism of Nasopharyngeal Carcinoma
Unknown status
- Nasopharyngeal Carcinoma
-
Taipei, TaiwanNational Taiwan University College of Medicine
Sep 9, 2005